Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000037891 | SCV000051367 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000037891 | SCV000061553 | benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.His83Gln in Exon 02 of BAG3: This variant is not expected to have clinical sig nificance because it has been identified in 1.0% (39/3738) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs151331972). |
Gene |
RCV000513197 | SCV000167153 | benign | not provided | 2018-11-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25617006, 30086531) |
Labcorp Genetics |
RCV001082899 | SCV000561198 | benign | Myofibrillar myopathy 6; Dilated cardiomyopathy 1HH | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000513197 | SCV000608570 | uncertain significance | not provided | 2017-03-01 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852640 | SCV000995345 | benign | Primary dilated cardiomyopathy | 2018-02-07 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988453 | SCV001138174 | benign | Myofibrillar myopathy 6 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000513197 | SCV001157652 | benign | not provided | 2020-08-11 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000037891 | SCV001433227 | benign | not specified | 2019-07-16 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000037891 | SCV001442729 | benign | not specified | 2020-10-01 | criteria provided, single submitter | clinical testing | Variant summary: BAG3 c.249C>A (p.His83Gln) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.001 in 282862 control chromosomes, predominantly at a frequency of 0.01 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 256 fold of the estimated maximal expected allele frequency for a pathogenic variant in BAG3 causing Dilated Cardiomyopathy phenotype (3.9e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. To our knowledge, no experimental evidence demonstrating its impact on protein function have been reported. Six ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance (1x) and benign (5x). Based on the evidence outlined above, the variant was classified as benign. |
CHEO Genetics Diagnostic Laboratory, |
RCV003149635 | SCV003837859 | benign | Cardiomyopathy | 2022-03-23 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000037891 | SCV001917283 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000037891 | SCV001965055 | benign | not specified | no assertion criteria provided | clinical testing |